Creative Planning’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Creative Planning’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-350	Closed	-$1K	–	2125
2018 Q4	$1K	Buy	+350	New	+$7.7K	﹤0.01%	1940

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XSC

X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Creative Planning's AVEO Position: Q3 2019 in Review

Creative Planning sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2019, closing a stake of 1,050 shares — an estimated $7K sold.

Creative Planning first reported a position in AVEO in Q1 2015 and held it in 15 quarters. The position peaked at $263K in Q3 2018. 59 funds tracked by Wall St. Rank hold AVEO as of Q3 2019.

Creative Planning reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Creative Planning sold 1,050 AVEO Pharmaceuticals, Inc. shares in Q3 2019, an estimated $7K.
Creative Planning first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2015 and held it in 15 quarters.
Creative Planning's AVEO Pharmaceuticals, Inc. position peaked at $263K in Q3 2018.
59 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2019.

Based on Creative Planning's 13F filing for Q3 2019, filed 1 Nov 2019.